tiprankstipranks
RHON-KLINIKUM AG (GB:0NQH)
LSE:0NQH
Holding GB:0NQH?
Track your performance easily

RHON-KLINIKUM AG (0NQH) Share Price & Analysis

0 Followers

0NQH Stock Chart & Stats


Financials

Annual

0NQH FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?
RHON-KLINIKUM AG lowest share price was €9.75 and its highest was €15.30 in the past 12 months.
    What is RHON-KLINIKUM AG’s market cap?
    RHON-KLINIKUM AG’s market cap is €970.61M.
      When is RHON-KLINIKUM AG’s upcoming earnings report date?
      RHON-KLINIKUM AG’s upcoming earnings report date is Feb 21, 2025 which is in 22 days.
        How were RHON-KLINIKUM AG’s earnings last quarter?
        RHON-KLINIKUM AG released its earnings results on Nov 07, 2024. The company reported €0.142 earnings per share for the quarter, beating the consensus estimate of N/A by €0.142.
          Is RHON-KLINIKUM AG overvalued?
          According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does RHON-KLINIKUM AG pay dividends?
            RHON-KLINIKUM AG pays a Notavailable dividend of €0.15 which represents an annual dividend yield of N/A. See more information on RHON-KLINIKUM AG dividends here
              What is RHON-KLINIKUM AG’s EPS estimate?
              RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does RHON-KLINIKUM AG have?
              RHON-KLINIKUM AG has 66,962,470 shares outstanding.
                What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?
                RHON-KLINIKUM AG reported an EPS of €0.142 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of RHON-KLINIKUM AG?
                  Currently, no hedge funds are holding shares in GB:0NQH
                  ---

                  RHON-KLINIKUM AG Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  45.00%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  3.56%
                  Trailing 12-Months
                  Asset Growth
                  4.73%
                  Trailing 12-Months

                  Company Description

                  RHON-KLINIKUM AG

                  Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Biotest
                  Fresenius Medical Care AG & Co. KGaA
                  Fresenius SE & Co. KGaA
                  Porsche Automobil Holding
                  Siemens Healthineers AG
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis